Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"></td><td align="center"><i>N</i></td><td align="center">%</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Overall response</td><td align="center">19</td><td align="center">47</td></tr><tr><td align="left">Complete response</td><td align="center">1</td><td align="center">3</td></tr><tr><td align="left">Partial response</td><td align="center">18</td><td align="center">44</td></tr><tr><td align="left">Stable disease <svg height="12.425" id="M6" style="vertical-align:-1.29163pt" version="1.1" viewbox="0 0 22.987499 12.425" width="22.987499" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,12.425)">
<g transform="translate(72,-62.06)">
<text transform="matrix(1,0,0,-1,-71.95,63.4)">
<tspan style="font-size: 12.50px; " x="0" y="0">≥</tspan>
<tspan style="font-size: 12.50px; " x="12.027886" y="0">6</tspan>
</text>
</g>
</g>
</svg> months</td><td align="center">7</td><td align="center">17</td></tr><tr><td align="left">Clinical benefit</td><td align="center">26</td><td align="center">64</td></tr><tr><td align="left">Progression</td><td align="center">15</td><td align="center">36</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Tumor Response (<svg height="10.8125" id="M5" style="vertical-align:-0.10033pt" version="1.1" viewbox="0 0 42.912498 10.8125" width="42.912498" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.8125)">
<g transform="translate(72,-63.35)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">4</tspan>
<tspan style="font-size: 12.50px; " x="27.969212" y="0">1</tspan>
</text>
</g>
</g>
</svg>).

Journal of Oncology

tab2

Table 2

Table 2: Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series 